ライフサイエンスコーパス: embolization

1 ablation (with transarterial chemo- or radio-embolization).

2 of 697 +/- 157 days (P < 0.001 versus before embolization).

3 ery embolization group (of whom 98 underwent embolization).

4 control animals, and were more sensitive to embolization.

5 rgery, and analyze the outcomes of lymphatic embolization.

6 haemorrhage and show its usefulness prior to embolization.

7 ical excision, stereotactic radiosurgery and embolization.

8 ears than those who underwent uterine-artery embolization.

9 to compare SNR measurements before and after embolization.

10 l anticoagulation strategies affect cerebral embolization.

11 Patients not eligible for ablation received embolization.

12 important drawbacks of intracranial aneurysm embolization.

13 -related complications; one of them required embolization.

14 ogically visible PAVMs too small to treat by embolization.

15 It was successfully treated with coil embolization.

16 December 27, 2010, prior to uterine fibroid embolization.

17 There were no complications secondary to embolization.

18 I lesions were seen, but 2 animals had renal embolization.

19 arge SPSSs that were considered eligible for embolization.

20 he three patients had symptoms of ZES before embolization.

21 entified bleeding site as well as palliative embolization.

22 nomas were selected if treated with arterial embolization.

23 ed today, making it a promising new tool for embolization.

24 riable atheromatous debris to prevent distal embolization.

25 al 2-stage hepatectomy including portal vein embolization.

26 cco are more prone to PAVM persistence after embolization.

27 occlusion and significantly reduced thrombus embolization.

28 e reliably even after failure of portal vein embolization.

29 viability of HCC treated with bland arterial embolization.

30 e long-term safety and efficacy of bariatric embolization.

31 al loss in the left eye (LE) two hours after embolization.

32 cessfully managed with a stent-assisted coil embolization.

33 ymphatic intervention, including complete TD embolization.

34 was achieved via sequential coronary artery embolizations.

35 was achieved via sequential coronary artery embolizations.

36 There were no MitraClip device embolizations.

37 these leaks may preclude clinically relevant embolizations.

38 death (16%), valve surgery (6%), late device embolization (0.4%), and new hemolysis requiring transfu

39 procedure-related strokes (0.078%); 9 device embolizations (0.24%) (6 requiring surgical removal); an

40 ents, and the main complications were device embolization (1.9%) and pericardial effusion (1.9%), wit

41 hort-term basis (i.e., within 100 days after embolization), 22 out of 37 patients (59.4%) were free o

42 0%, 3%, 4%, P < 0.001), need for portal vein embolization (5%, 9%, 9%, P = 0.001), preoperative chemo

43 safety, and short-term efficacy of bariatric embolization, a recently developed endovascular procedur

44 etic resonance imaging and hypothesized that embolization acutely decreases SPC flow and increases sy

45 curative exclusion of AVM from circulation, embolization adjuvant to resection or radiation therapy,

46 Six months after embolization, all the 3 patients had a clinical and comp

47 8 consecutive patients with liver lymphatic embolization and congenital heart disease with elevated

48 atient received a combination of transvenous embolization and hybrid sclerotherapy.

49 rvention aims to decrease the rate of distal embolization and impaired myocardial reperfusion after p

50 nger or appetite decreased for 4 weeks after embolization and increased thereafter, without reaching

51 and the presumed but not proven mechanism is embolization and occlusion of end arterioles.

52 dity post-embolization, and the time between embolization and surgery were similar between the groups

53 by-case basis between transcatheter arterial embolization and surgery.

54 ac myxomas, chemotherapy, radiotherapy, coil embolization and surgical treatment could be helpful.

55 The fistula was occluded with embolization and the patient showed recovery following t

56 on of glomus jugulare tumors with the use of embolization and the subtotal occlusion poses a high ris

57 ity, which has ramifications for the growth, embolization, and lysis of thrombi.

58 els: partial hepatectomy, portal ligature or embolization, and radiotherapy or chemotherapeutic drugs

59 vironmental conditions, may account for some embolization, and suggest a target for therapeutic inter

60 periority of chemoembolization compared with embolization, and the role of chemotherapy remains uncle

61 Morbidity post-embolization, and the time between embolization and surg

62 s resulted in loss of stent integrity, stent embolization, aortic wall injury, or reobstruction.

63 Percutaneous embolization appears to be the best method of treatment

64 us formation, regression, or probability for embolization are largely unknown.

65 In this study, the results of embolization are presented, and the literature results a

66 cal treatment, myomectomy and uterine-artery embolization are therapeutic options.

67 owever, the safety and efficacy of bariatric embolization are unknown.

68 ymphangiographic imaging and liver lymphatic embolization as a treatment for PLE.

69 ws commercially available materials used for embolization as well as polymeric materials that are und

70 An accurate pre-embolization assessment of bleeding with CT angiography

71 This facilitates angiographic monitoring of embolization at any stage.

72 An alternative approach using radiopaque embolization beads loaded with the antiangiogenic drug v

73 nce of severe aortic regurgitation, abscess, embolization before surgical treatment, and transfer fro

74 percutaneous puncture of pseudoaneurysm and embolization by coils.

75 ssessed with all modalities before and after embolization by using a qualitative three-point scale sc

76 and perfusion were measured before and after embolization by using velocity-encoded and perfusion MR

77 Bariatric embolization can significantly suppress ghrelin and sign

78 The best volumetric embolization conditions, which resulted in the regenerat

79 We report on the acute efficacy of SPC embolization, demonstrating a significant decrease in SP

80 biological modification have become routine embolization devices to reduce the risk of cerebral aneu

81 arteriography performed with the purpose of embolization did not reveal the pseudoaneurysm.

82 ar occlusion (rate or duration), portal vein embolization, drain use, etc.)(p > 0.05).

83 polymer mesh, was designed to reduce distal embolization during percutaneous coronary intervention i

84 nted in all patients, with no cases of valve embolization, ectopic valve deployment, or additional va

85 imited by recanalization, risk of non-target embolization, failure in coagulopathic patients, high co

86 respiratory distress syndrome from Lipiodol embolization following transarterial chemoembolization c

87 atively (with the assistance of angiographic embolization for 25 patients).

88 were no significant differences in cerebral embolization for bivalirudin versus heparin anticoagulat

89 cluded patients who underwent bland arterial embolization for HCC between 2006 and 2016 and subsequen

90 er of gastrinoma patients treated with liver embolization for liver metastases were found, and simila

91 group and 80.0+/-22.0 in the uterine-artery embolization group (mean adjusted difference with comple

92 nt myomectomy) and 127 to the uterine-artery embolization group (of whom 98 underwent embolization).

93 nd in 24% of the women in the uterine-artery embolization group.

94 in hypertrophy response between the other 3 embolization groups.

95 orted active tobacco use at the time of PAVM embolization had a 5-year cumulative incidence of persis

96 Gas embolization has been proposed as a fast, easily adminis

97 The acute efficacy of SPC embolization has not been demonstrated in a quantifiable

98 Superselective transcatheter embolization has shown to be an effective and safe thera

99 ical examples of injury from (90)Y nontarget embolization have likely resulted from relatively large

100 transcatheter therapies such as portal vein embolization, hepatic artery infusion chemotherapy, tran

101 tal/mycotic aneurysms are often managed with embolization if feasible.

102 stage of the procedure, access, portal vein embolization, if used, types of transection and hepatect

103 Portal vein embolization improves the safety of liver resection by i

104 (0.65%), because of dysrhythmia in 2, device embolization in 1, and cardiac erosion in 3.

105 rformed in 55 aneurysms (83.3%), and partial embolization in 11 aneurysms (16.7%).

106 Procedural mortality was 3.6%, with TAV embolization in 2.2% and conversion to surgery in 2.2%.

107 present in 25 aneurysms (86.2%), and partial embolization in 4 aneurysms (13.8%), respectively.

108 respiratory distress syndrome from Lipiodol embolization in a patient who underwent transarterial ch

109 urosurgical grafting in 2 patients and tumor embolization in a third).

110 gle ischemic insult) in 16 pigs and coronary embolization in eight of the 16 pigs (32 mm(3), 40-120 m

111 ion (HAL), which recapitulates transarterial embolization in mouse models, to enhance the efficacy of

112 This study documented cerebral embolization in nearly two-thirds of patients during con

113 t frequent applications of selective splenic embolization in patients with and without underlying cir

114 arteriovenous malformation persistence after embolization in patients with hereditary hemorrhagic tel

115 valuate the safety and efficacy of bariatric embolization in severely obese adults at up to 12 months

116 be rescued with exogenous ADP and increased embolization in Stx8(-/-) mice in vivo consistent with a

117 ation and subsequent occlusion or downstream embolization in the coronary artery was the key to devel

118 ogel is shown in a porcine survival model of embolization in the iliac artery and the renal artery.

119 d safety of selective transcatheter arterial embolization in three consecutive UC patients diagnosed

120 , and severity of the worst HE episode after embolization in three-quarters of the patients.

121 terventional therapy (including endovascular embolization) in preventing death or stroke.

122 ple endovascular procedure (ie, renal artery embolization) in vivo and to compare with x-ray guidance

123 myomectomy, as compared with uterine-artery embolization, in women who had symptomatic uterine fibro

124 Methods for preventing off-target embolization, increasing the specificity of microsphere

125 Minimally invasive transcatheter embolization is a common nonsurgical procedure in interv

126 Cerebral embolization is a frequent complication after transcathe

127 Vascular embolization is a life-saving minimally invasive cathete

128 Transcatheter embolization is a minimally invasive procedure that uses

129 Background Bariatric embolization is a new endovascular procedure to treat pa

130 esults suggest that selective intra-arterial embolization is a safe and painless procedure that is we

131 Selective liver embolization is an effective and safe therapy for the tr

132 Portal vein embolization is associated with increased TGR and new tu

133 Conclusion Percutaneous transarterial embolization is effective for the emergency treatment of

134 Conclusion Bariatric embolization is feasible and appears to be well tolerate

135 Transcatheter arterial embolization is not an effective therapeutic approach in

136 Transarterial embolization is one therapy clinically used in these cas

137 Background Embolization is the standard of care for treatment of pu

138 PAVM occlusion by embolization is the standard of care to reduce these ris

139 Embolization is the treatment of choice in the case of s

140 In the cases of unresectable tumors embolization is used as a palliative procedure.

141 Conclusion Bariatric embolization is well tolerated in severely obese adults,

142 In a large animal model of vascular embolization, it is shown that the BEM can be prepared a

143 with chronic LBBB combined with infarction (embolization; LBBB plus myocardial infarction, and conce

144 Lymphatic embolization led to improved albumin levels and relief o

145 d increased thereafter, without reaching pre-embolization levels.

146 nd avoid the complications of splenic artery embolization like infarcts and abscess.

147 cteristics (size, complexity, and location), embolization material used, microcatheter type, smoking

148 Application of temporary, absorbable embolization materials could be advantageous in some sit

149 We hypothesized that cerebral embolization may be reduced by anticoagulation with biva

150 to identify anatomic factors predisposing to embolization may help improve stroke prediction in patie

151 creasing the size of residual liver, but the embolization may increase tumor growth during the waitin

152 ic artery ligation n = 26; resection n = 13; embolization n = 1) was required in 40 (32%).

153 increase in PVR generated by acute pulmonary embolization (n = 10); 2) serial changes in PVR in chron

154 bnormal first rib (n = 3), and/or history of embolization (n = 2).

155 ervention) vs intervention (any endovascular embolization, neurosurgical excision, or stereotactic ra

156 width, sac-to-neck ratio, initial result of embolization, number of coils used and the use of hydrog

157 Stent embolization occurred in 1 patient; another required dra

158 adiological thrombosis extension or clinical embolization occurred in the 126 children assessed at fo

159 Persistence of PAVMs after embolization occurs for undefined reasons but may includ

160 ce interval,1.07-5.67) and valve dislodgment/embolization (odds ratio, 4.36; 95% CI, 1.21-15.69); new

161 was necessary and it resulted in a complete embolization of 5 aneurysms.

162 Cerebral embolization of air microbubbles or microparticulate deb

163 rdiac catheterization with coil and particle embolization of angiographically evident SPC vessels.

164 Embolization of branches of the left gastric artery that

165 rvey of the literature made us conclude that embolization of cavernous artery by means of an autologo

166 ears to be a safe and efficient material for embolization of cerebral AVMs, also in cases of intracra

167 VICE 10: Prophylactic transcatheter arterial embolization of high-risk ulcers after successful endosc

168 findings suggest that detachment and distal embolization of hydrophilic-coating material from corona

169 Distal embolization of hydrophilic-coating material was observe

170 Embolization of kidney cancer in particular cases may be

171 efficacy and safety of patients treated with embolization of large SPSSs for the treatment of chronic

172 respiratory distress syndrome from pulmonary embolization of Lipiodol, an iodinated oil commonly used

173 Embolization of liver metastases might reduce symptoms o

174 latinum-containing systemic chemotherapy; 3) embolization of segments 5-8 versus 4-8; and 4) baseline

175 Curative embolization of small cerebral AVMs is an efficient and

176 We highlighted the use of pre-operative embolization of such a vascular rib lesion before surgic

177 mal model of PEI, steatorrhea was induced by embolization of the exocrine pancreas gland and pancreat

178 phthalmic artery occlusion after Embozene(R) embolization of the external carotid artery (ECA).

179 re.(The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial [LOSEIT]; NCT03

180 Transarterial embolization of the gastric fundus was performed using 3

181 Transarterial embolization of the gastric fundus with fluoroscopic gui

182 This was followed by coil embolization of the HAA with improvement in symptoms and

183 The resultant embolization of the infected clot can contribute to the

184 nt sessions in most patients, with selective embolization of the left and right liver lobes within 6

185 Thus, selective radiological embolization of the left hepatic artery branches was nec

186 Our patient was treated by embolization of the lesion with 20% glue, after which he

187 He subsequently underwent embolization of the maxillary branch of the left ECA usi

188 in 15 (83.4%); one patient required a second embolization of the medial rectal artery and two require

189 The patient was successfully treated by embolization of the penile artery with an autologous clo

190 ing or retrieval of the valve prosthesis and embolization of the prosthesis; and other complications.

191 A selective embolization of the right hepatic artery was carried out

192 1 mixture of NBCA and lipiodol were used for embolization of the spermatic vein.

193 sed concerns about detachment and subsequent embolization of these hydrophilic coatings.

194 ubstantiated the effectiveness and safety of embolization of these shunts, provided there is sufficie

195 d, this could enhance thrombus formation and embolization of thrombi around the device into the circu

196 tent foramen ovale (PFO) may permit arterial embolization of thrombi that accumulate on the leads of

197 and evaluate a novel method of endovascular embolization of varicoceles using n-butyl cyanoacrylate

198 Embolization of varicoceles using NBCA glue is efficient

199 4%) were free of HE (P < 0.001 versus before embolization) of which 18 (48.6% of patients overall) re

200 e sought to assess the acute efficacy of SPC embolization on blood flow as quantified by phase contra

201 f shear rate, suggesting a potential risk of embolization on treatment with PI3Kbeta inhibitors.

202 were successfully treated with intravascular embolization; one patient underwent additional hemostati

203 What is the likelihood of distal embolization or periprocedural myocardial infarction dur

204 icult to control; they often re-expand after embolization or resection, and pharmacologic therapy is

205 he treatment usually involves trans-arterial embolization or surgical resection.

206 outflow tract obstruction, device migration, embolization, or conversion to mitral surgery.

207 8%, with no cases of disabling stroke, valve embolization, or major/life-threatening bleeding complic

208 cond valve implantation (P=0.013), and valve embolization (P=0.009) in the ER group.

209 edian Q(P):Q(S) from 1.3 before to 0.8 after embolization (P=0.03), and an increase in Q(S) from a me

210 d Long-term experience with prostatic artery embolization (PAE) for benign prostatic hyperplasia rema

211 predictors of outcome after prostate artery embolization (PAE) for benign prostatic hyperplasia with

212 rvention to decrease the incidence of distal embolization, periprocedural myocardial infarction, and

213 ation]; age range, 12-72 years) who had PAVM embolization, persistence by computed tomography (CT), a

214 While there are numerous drawbacks to coil embolization, physician expertise, availability of these

215 ximum of 19 mm Hg (SD, 4.5 mm Hg) due to the embolization procedure.

216 were measured for MR-guided and x-ray-guided embolization procedures and are presented as means +/- s

217 Percutaneous transcatheter embolization procedures involve the selective occlusion

218 en of 18 patients underwent either lymphatic embolization procedures or thoracic duct stenting with c

219 p, tattoos, hairbands, clothes, endovascular embolization, prostheses, surgical clips, intraorbital a

220 y and efficacy of percutaneous transarterial embolization (PTAE) for the treatment of spontaneous sof

221 trospective study was to compare portal vein embolization (PVE) and radiologica simultaneous portohep

222 the future liver remnant (FLR), portal vein embolization (PVE) of the tumor-bearing liver is used to

223 After portal vein embolization (PVE), 15% of patients remain ineligible fo

224 acute increases in PVR induced by pulmonary embolization (r = -0.92), serial PVR fluctuations in chr

225 d radiologica simultaneous portohepatic vein embolization (RASPE) for future liver remnant (FLR) grow

226 es, hepatic function, ASA class, portal vein embolization rate)(p > 0.05).

227 the anterior cerebral circulation, thrombus embolization resulting in Willisian collateral failure m

228 Transarterial-chemo-embolization (TACE) is used for palliation of unresectab

229 Transarterial embolization (TAE) has been extensively used to manage u

230 radiopaque microspheres during transarterial embolization (TAE) in the VX2 rabbit liver tumor model b

231 Local recurrence after transarterial embolization (TAE) of hepatocellular carcinoma (HCC) pro

232 which was followed by transcatheter arterial embolization (TAE) of the BAA and of the pathological br

233 ucing ischemic cell death with transarterial embolization (TAE) or transarterial chemoembolization (T

234 s factors after bland transcatheter arterial embolization (TAE), a purely ischemic treatment for hepa

235 d to potentiate treatment with transarterial embolization (TAE).

236 surviving ischemia induced by transarterial embolization (TAE)/transarterial chemoembolization (TACE

237 The standard coil embolization technique is limited by its inability to oc

238 Three patients had stent embolization that required surgical correction in 2 but

239 udy inclusion after surgical or angiographic embolization to control bleeding (D1), and then three ti

240 s and embolic agents since Duggan introduced embolization to management of postraumatic epistaxis in

241 In (90)Y radioembolization, nontarget embolization to the stomach or small bowel can result in

242 andom assignment was stratified by number of embolizations to complete treatment, and assignments wer

243 for utilization of preoperative portal vein embolization, transjugular intrahepatic portosystemic sh

244 : Authors analyzed the efficacy of selective embolization treatment of haemorrhage in advanced head a

245 and 6 women) and scheduled for endovascular embolization treatment were prospectively included.

246 the first (TV-in-TV) or transcatheter valve embolization (TVE) after transcatheter aortic valve repl

247 s of study design, anticancer drug, RT type, embolization type, presence of portal venous tumor throm

248 nts, study design, anticancer drug, RT type, embolization type, presence of PVTT, and time between TA

249 e in the literature regarding uterine artery embolization (UAE).

250 (compared with myomectomy or uterine artery embolization [UAE]), but rates of more serious complicat

251 ter conventional and partial uterine fibroid embolization (UFE).

252 d with successful percutaneous transcatheter embolization under emergency conditions.

253 easible for renal artery catheterization and embolization under real-time MR imaging in vivo, and qua

254 shear rate, highlighting a potential risk of embolization upon PI3Kbeta inhibition.

255 his randomized trial compares the outcome of embolization using microspheres alone with chemoemboliza

256 umetric (distal, partial, and random) portal embolization (VPE), which preserves total liver volume.

257 In the PVE group, the FLR/TLV ratio before embolization was 31.03% (range: 18.33%-38.95%) versus 22

258 Conclusion Prostatic artery embolization was a safe and effective procedure for beni

259 In 160 patients, partial embolization was intentionally performed to preserve fer

260 experiments, the therapeutic efficacy of gas embolization was investigated in an ectopic xenograft mo

261 In 6 aneurysms (9.1%), re-embolization was necessary and it resulted in a complete

262 Coil embolization was not possible due to the small caliber o

263 Bariatric embolization was performed by infusion of 40-mum calibra

264 Surgery or embolization was performed in 11 of the 22 patients with

265 A complete embolization was performed in 55 aneurysms (83.3%), and

266 Embolization was performed in the portal trunk of C57BL6

267 Results Bariatric embolization was performed successfully for all particip

268 The successful embolization was performed to ultimately stop the bleedi

269 An ad hoc coil embolization was performed with angiographic success.

270 nteric arteries, and selective transcatheter embolization was performed with immediate technical succ

271 Transarterial embolization was planned but repeat cerebral angiography

272 On a follow-up DSA, complete embolization was present in 25 aneurysms (86.2%), and pa

273 Tumor embolization was proceeded as a minimally invasive proce

274 A marked increase in embolization was seen following FeCl3 injury in GPVI-def

275 Results Embolization was successful in all six kidneys under bot

276 Lymphatic embolization was successful in patients with traumatic l

277 Coil embolization was tried but the coil dislodged into the r

278 rforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and 0.45% for RVEMB, w

279 After embolization, we found a significant decrease in SPC flo

280 rotocol, in vivo renal artery navigation and embolization were tested in three farm pigs (mean weight

281 e balloon postdilation and valve dislodgment/embolization were the predictors of acute CVEs, new-onse

282 llular carcinoma treated with bland arterial embolization when lesions were assessed as Viable or Non

283 nsidered as an alternative to trans-arterial embolization when the pseudoaneurysm cannot be visualize

284 Six swine underwent bariatric embolization, while six control animals underwent a sham

285 matemesis, who was successfully treated with embolization with a 1:2 dilution of N-butyl cyanoacrylat

286 We examined whether experimental lung embolization with autologous blood clots or with the inf

287 Embolization with blood clots or microspheres increased

288 Embolization with combined particle sizes (100-500 mum)

289 s also the therapeutic challenge of a failed embolization with consequent microcoil migration and pri

290 Liver lymphatic embolization with ethiodized oil in 2 patients resulted

291 Endovascular embolization with hydrogel coils is an effective and saf

292 patients with HCC were randomly assigned to embolization with microspheres alone (Bead Block [BB]) o

293 mptoms after resection of the varix, 2 after embolization with n-butyl cyanoacrylate and 2 via a righ

294 Of the remaining 6 patients, liver lymphatic embolization with n-butyl cyanoacrylate glue resulted in

295 t true aneurysm we performed an endovascular embolization with N-butyl-cyano-acrylate (NBCA) glue.

296 ent was discharged in good general condition Embolization with NBCA can be an efficient method to tre

297 reatments such as shunt and variceal complex embolization with or without transjugular intrahepatic p

298 usion of chemotherapeutic agents followed by embolization with particles.

299 nt and emerging technologies in endovascular embolization with respect to devices, materials, mechani

300 recurrent, even after n-butyl cyanoacrylate embolization, with repeated Valsalva-type maneuvers.